Sign In
Buy SNN
$31.56
-0.770 (-2.38%)
At Close: Jul 31, 2026
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 02'nd Sep 2025
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the better value oppo
SNN vs. SYK: Which Stock Is the Better Value Option?
12:40pm, Friday, 15'th Aug 2025
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Smith & Nephew: US bank upbeat after meetings with management
09:51am, Monday, 11'th Aug 2025
Citi has reiterated its buy rating on Smith & Nephew PLC (LSE:SN) following recent meetings with the company's CEO and CFO. The bank highlights a constructive tone around the business despite the deci
Smith & Nephew: Doing Better And Still Offers Value
11:37am, Thursday, 07'th Aug 2025
Smith & Nephew's interim results confirm solid progress, with revenue up 5% and strong cash flow growth, supporting my continued 'buy' rating. Dividend growth has resumed after years of stagnation, an
US bank ‘buy' on Smith & Nephew after better-than-expected results and $500m buyback
08:46am, Wednesday, 06'th Aug 2025
Citi has stuck with its ‘buy' call on Smith & Nephew PLC (LSE:SN) after the company delivered quarterly results that were, in Citi's words, “meaningfully better than expected”, and announced a
Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript
10:06am, Tuesday, 05'th Aug 2025
Smith & Nephew plc (NYSE:SNN ) Q2 2025 Earnings Conference Call August 5, 2025 3:30 AM ET Company Participants Deepak S. Nath - CEO & Director John Terence Rogers - CFO & Executive Director Conference
Smith+Nephew jumps 14% on earnings beat and buyback
09:46am, Tuesday, 05'th Aug 2025
Smith & Nephew PLC (LSE:SN) shares surged 14% after the company reported robust revenue and profit growth, and announced a $500 million share buyback to be launched in the second half of the year. The
Top 2 Health Care Stocks You May Want To Dump In Q3
09:11am, Tuesday, 05'th Aug 2025
As of Aug. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Smith+Nephew maintain guidance as it lifts profits and cash flow, launches $500 million buyback after strong first half
02:38am, Tuesday, 05'th Aug 2025
Smith & Nephew PLC (LSE:SN) maintained full-year guidance after reporting robust revenue growth and rising profitability on Tuesday, as the medical technology company posted strong sets of results
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 28'th Jul 2025
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity ri
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
10:41am, Monday, 28'th Jul 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Smith & Nephew: Quiet start for med-tech giant as pressure mounts
04:51am, Monday, 28'th Jul 2025
It was a quiet start to the week for shares in Smith & Nephew PLC (LSE:SN). But perhaps it is the calm before the storm for the medical devices giant, which faces a shareholder revolt.
SNN or ESLOY: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 11'th Jul 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks is mor
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
10:41am, Friday, 11'th Jul 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
10:00am, Monday, 07'th Jul 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint
